BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 29863255)

  • 1. MicroRNA-221: biogenesis, function and signatures in human cancers.
    Abak A; Amini S; Sakhinia E; Abhari A
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer.
    Duan J; Zhang H; Qu Y; Deng T; Huang D; Liu R; Zhang L; Bai M; Zhou L; Ying G; Ba Y
    Oncotarget; 2016 Jul; 7(28):44522-44533. PubMed ID: 27304191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
    Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
    Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.
    Hua Y; Larsen N; Kalyana-Sundaram S; Kjems J; Chinnaiyan AM; Peter ME
    BMC Genomics; 2013 Mar; 14():179. PubMed ID: 23497354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential.
    Nie D; Fu J; Chen H; Cheng J; Fu J
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
    Pilyugin M; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the miR-200 family in epithelial-mesenchymal transition.
    Mongroo PS; Rustgi AK
    Cancer Biol Ther; 2010 Aug; 10(3):219-22. PubMed ID: 20592490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer.
    Zhong X; Zheng L; Shen J; Zhang D; Xiong M; Zhang Y; He X; Tanyi JL; Yang F; Montone KT; Chen X; Xu C; Xiang AP; Huang Q; Xu X; Zhang L
    Mol Cell Biol; 2016 Nov; 36(21):2742-2754. PubMed ID: 27550813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNA-410 in molecular oncology: A double edged sword.
    Wen R; Umeano AC; Essegian DJ; Sabitaliyevich UY; Wang K; Farooqi AA
    J Cell Biochem; 2018 Nov; 119(11):8737-8742. PubMed ID: 30086210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and prostate cancer.
    Pang Y; Young CY; Yuan H
    Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):363-9. PubMed ID: 20539944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
    Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
    Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
    Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma.
    Ling N; Gu J; Lei Z; Li M; Zhao J; Zhang HT; Li X
    Oncol Rep; 2013 Nov; 30(5):2111-8. PubMed ID: 23970205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
    Cao Z; Qiu J; Yang G; Liu Y; Luo W; You L; Zheng L; Zhang T
    Cancer Biol Med; 2020 Aug; 17(3):569-582. PubMed ID: 32944391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.